[go: up one dir, main page]

AU5260698A - Composition and treatment for persistent reproductive transition symptoms - Google Patents

Composition and treatment for persistent reproductive transition symptoms

Info

Publication number
AU5260698A
AU5260698A AU52606/98A AU5260698A AU5260698A AU 5260698 A AU5260698 A AU 5260698A AU 52606/98 A AU52606/98 A AU 52606/98A AU 5260698 A AU5260698 A AU 5260698A AU 5260698 A AU5260698 A AU 5260698A
Authority
AU
Australia
Prior art keywords
persistent
symptoms
treatment
composition
reproductive transition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52606/98A
Inventor
Lewis D. Lepene
Judith J. Wurtman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Internutria Inc
Original Assignee
Internutria Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Internutria Inc filed Critical Internutria Inc
Publication of AU5260698A publication Critical patent/AU5260698A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU52606/98A 1996-11-18 1997-11-18 Composition and treatment for persistent reproductive transition symptoms Abandoned AU5260698A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75159096A 1996-11-18 1996-11-18
US08751590 1996-11-18
PCT/US1997/020957 WO1998021946A1 (en) 1996-11-18 1997-11-18 Composition and treatment for persistent reproductive transition symptoms

Publications (1)

Publication Number Publication Date
AU5260698A true AU5260698A (en) 1998-06-10

Family

ID=25022684

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52606/98A Abandoned AU5260698A (en) 1996-11-18 1997-11-18 Composition and treatment for persistent reproductive transition symptoms

Country Status (2)

Country Link
AU (1) AU5260698A (en)
WO (1) WO1998021946A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2287965C (en) * 1997-05-01 2009-10-20 Graham Edmund Kelly Treatment or prevention of menopausal symptoms and osteoporosis
US20020160060A1 (en) * 1999-04-26 2002-10-31 Mandy Kim Chen Enriched spreads
AUPQ008299A0 (en) * 1999-04-30 1999-05-27 G.J. Consultants Pty Ltd Isoflavone metabolites
AU4402600A (en) * 1999-05-18 2000-12-05 Rawlings, Anthony V. Fat containing products
WO2001003687A2 (en) * 1999-07-13 2001-01-18 Cedars-Sinai Medical Center Method and compositions for inhibiting biosynthesis or bioactivity of endogenous steroid sex hormones in humans
EP1132084A1 (en) * 2000-03-06 2001-09-12 Docteur Nature Srl Transdermal device for the slow release of soybean derived vegetable estrogens
FR2813790B1 (en) * 2000-09-11 2004-03-12 Dolisos Lab PHARMACEUTICAL PREPARATIONS CONTAINING SOY ISOFLAVONE EXTRACTS AND PROBIOTIC MICROORGANISMS
US6559177B2 (en) 2001-04-19 2003-05-06 Wyeth 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
US6589980B2 (en) 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
US20030150012A1 (en) * 2001-06-13 2003-08-07 Odell Joan T. Method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant
WO2003004039A2 (en) * 2001-07-03 2003-01-16 Nutri Pharma Danmark Holding A/S Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
US6787151B2 (en) 2001-08-10 2004-09-07 Lipton, Division Of Conopco, Inc. Composition for lowering blood cholesterol
WO2003102072A1 (en) * 2002-05-30 2003-12-11 Granate Seed Limited Starch products involving a starch-lipid complex, their preparation and uses
FI20021184A (en) 2002-06-19 2003-12-20 Hormos Nutraceutical Oy Ltd Lignaanivalmisteita
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
US7396855B2 (en) * 2002-07-24 2008-07-08 Children's Hospital Medical Center Compositions and products containing S-equol, and methods for their making
JP4889944B2 (en) 2002-10-29 2012-03-07 コロラド ステート ユニバーシティー リサーチ ファウンデーション Use of equol to treat androgen-mediated diseases
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
PA8656601A1 (en) * 2004-12-17 2006-12-07 Wyeth Wyeth NEW USES FOR BETA DE ESTROGEN AGONISTS
JP2008526819A (en) * 2005-01-10 2008-07-24 ホルモス メディカル リミテッド Use of lignans for the manufacture of a composition for preventing or ameliorating symptoms associated with estrogen deficiency
CN108714236B (en) * 2018-06-19 2020-03-20 北京化工大学 Starch-choline composite system and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949085A (en) * 1970-05-27 1976-04-06 Chinoin Gyogyszer-Es Vegyeszeti Termakek Gyara Rt Anabolic-weight-gain promoting compositions containing isoflavone derivatives and method using same
US4166862A (en) * 1971-05-25 1979-09-04 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Animal feed containing anabolic isoflavones
WO1994023716A1 (en) * 1993-04-16 1994-10-27 Tufts University School Of Medicine Method for treatment of menopausal and premenstrual symptoms
US5424331A (en) * 1994-06-10 1995-06-13 Bio-Virus Research Incorporated Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
US5516528A (en) * 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy

Also Published As

Publication number Publication date
WO1998021946A1 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
AU5260698A (en) Composition and treatment for persistent reproductive transition symptoms
AU1694497A (en) Disinfecting compositions and processes for disinfecting surfaces
AU1884797A (en) Improvements in or relating to contrast agents
AU4714797A (en) Improvements in or relating to contrast agents
AU5081298A (en) Surgical method and composition therefor
AU8693098A (en) Compositions and methods for treating diabetes
AU2784397A (en) Contrast agents
AU4813197A (en) Compositions and methods for treating viral infections
AU4266596A (en) Composition and use
AU2327599A (en) Compositions and methods for treating autoimmune diseases
AU3308195A (en) Antihypertriglyceridemic composition
AU2100997A (en) Composition containing iso-flavonoids and lignans
AU2310395A (en) Topical retinal-based composition
AU4919597A (en) Synergistic composition comprising rapamycin and calcitriol
AU3200197A (en) New composition and methods
AU1658997A (en) Topical composition
AU5260798A (en) Compositions and treatment for nighttime persistent reproductive transition symptoms
AUPO982097A0 (en) Methods and compositions for use therein
AU3164795A (en) Compositions for alkalinizing and energy-boosting drinks
AU691690B2 (en) Acrolein-releasing composition and use thereof
AU2149600A (en) Methods and compositions for treating common cold symptoms
AU5257198A (en) Compositions and methods for treating type ii diabetes involving hnf-4
AU2713797A (en) Depigmentating agent in the treatment of melasma
AU2813195A (en) Composition
AU3423397A (en) Therapeutic methods and compositions for use therein